{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:28Z","timestamp":1772165608970,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uncomplicated urinary tract infection (uUTI) is very common among women in primary care. The risk of developing pyelonephritis remains low after uUTI, nonetheless, empiric antibiotic therapy is frequently prescribed for symptomatic purposes. This may lead to adverse effects and antibiotic resistance. Furthermore, patients may express the will to limit the use of antibiotics. Some European countries recommend discussing a delayed prescription with the patient and developing a shared decision. The aim of this study is to create a patient decision aid (PtDA) used in primary care settings to make a shared decision between practitioners and women about whether or not to treat uUTI with antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We followed the steps recommended by the International Patient Decision Aids Standards, with a scoping phase, a design phase (including focus groups and literature review), and an alpha-testing phase. A steering group, made of patients and physicians, met throughout the study to develop a prototype PtDA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The information included in the PtDA is the definition of uUTI, information on the options, their benefits, risks, and consequences, based on a review of the literature. The results of the focus group made possible to determine the patient\u2019s values and preferences to consider in decision-making, including: the discomfort felt, the impact on daily life, patients\u2019 perceptions of antibiotics, and the position relative to the risk of adverse effect. The choices in presentation, organisation and design are the result of the work of the steering group, improved by feedback from alpha testing. We confirmed the need for shared decision-making and the equipoise in this situation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed a PtDA to be used in primary care for sharing decision on the use of antibiotic in uUTI. It needs to be validated in a beta-testing phase, with complementary advice from peers, and then tested in a clinical study comparing its use with the systematic prescription approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12875-021-01374-3","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T16:20:07Z","timestamp":1611678007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-6931","authenticated-orcid":false,"given":"Yves-Marie","family":"Vincent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad\u00e8le","family":"Frachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Buffeteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Conort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"1374_CR1","first-page":"752","volume":"52","author":"E Hummers-Pradier","year":"2002","unstructured":"Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract. 2002;52:752\u201361.","journal-title":"Br J Gen Pract"},{"key":"1374_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","volume":"10","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, D\u2019Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509\u201315.","journal-title":"Ann Epidemiol"},{"key":"1374_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2296-15-162","volume":"15","author":"A Flower","year":"2014","unstructured":"Flower A, Bishop FL, Lewith G. How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC Fam Pract. 2014;15:162.","journal-title":"BMC Fam Pract"},{"key":"1374_CR4","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.3399\/bjgp15X686965","volume":"65","author":"CC Butler","year":"2015","unstructured":"Butler CC, Hawking MK, Quigley A, McNulty CA. Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey. Br J Gen Pract. 2015;65:e702\u20137.","journal-title":"Br J Gen Pract"},{"key":"1374_CR5","first-page":"729","volume":"52","author":"TCM Christiaens","year":"2002","unstructured":"Christiaens TCM, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract. 2002;52:729\u201334.","journal-title":"Br J Gen Pract"},{"key":"1374_CR6","first-page":"91","volume":"58","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Inf Secur. 2009;58:91\u2013102.","journal-title":"J Inf Secur"},{"key":"1374_CR7","doi-asserted-by":"publisher","first-page":"c279","DOI":"10.1136\/bmj.c279","volume":"340","author":"GM Leydon","year":"2010","unstructured":"Leydon GM, Turner S, Smith H, Little P. UTIS team. Women\u2019s views about management and cause of urinary tract infection: qualitative interview study. BMJ. 2010;340:c279.","journal-title":"BMJ"},{"key":"1374_CR8","doi-asserted-by":"publisher","unstructured":"Duane S, Domegan C, Callan A, Galvin S, Cormican M, Bennett K, et al. Using qualitative insights to change practice: exploring the culture of antibiotic prescribing and consumption for urinary tract infections. BMJ Open. 2016;6. https:\/\/doi.org\/10.1136\/bmjopen-2015-008894.","DOI":"10.1136\/bmjopen-2015-008894"},{"key":"1374_CR9","doi-asserted-by":"publisher","first-page":"h6544","DOI":"10.1136\/bmj.h6544","volume":"351","author":"I G\u00e1gyor","year":"2015","unstructured":"G\u00e1gyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ. 2015;351:h6544.","journal-title":"BMJ."},{"key":"1374_CR10","doi-asserted-by":"publisher","unstructured":"Vik I, Bollestad M, Grude N, B\u00e6rheim A, Damsgaard E, Neumark T, et al. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women\u2014a double-blind, randomized non-inferiority trial. PLoS Med. 2018;15. https:\/\/doi.org\/10.1371\/journal.pmed.1002569.","DOI":"10.1371\/journal.pmed.1002569"},{"key":"1374_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","volume":"366","author":"TM Hooton","year":"2012","unstructured":"Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366:1028\u201337.","journal-title":"N Engl J Med"},{"key":"1374_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijantimicag.2019.06.015","volume":"54","author":"K Malmros","year":"2019","unstructured":"Malmros K, Huttner BD, McNulty C, Rodr\u00edguez-Ba\u00f1o J, Pulcini C, T\u00e4ngd\u00e9n T. Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: results of an online survey. Int J Antimicrob Agents. 2019;54:478\u201386.","journal-title":"Int J Antimicrob Agents"},{"key":"1374_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","volume":"48","author":"F Caron","year":"2018","unstructured":"Caron F, Galperine T, Flateau C, Azria R, Bonacorsi S, Bruy\u00e8re F, et al. Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect. 2018;48:327\u201358.","journal-title":"Med Mal Infect"},{"key":"1374_CR14","doi-asserted-by":"publisher","first-page":"e830","DOI":"10.3399\/bjgp17X693641","volume":"67","author":"CC Butler","year":"2017","unstructured":"Butler CC, Francis N, Thomas-Jones E, Llor C, Bongard E, Moore M, et al. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. Br J Gen Pract. 2017;67:e830\u201341.","journal-title":"Br J Gen Pract"},{"key":"1374_CR15","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103\u201320.","journal-title":"Clin Infect Dis"},{"key":"1374_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s15010-016-0910-2","volume":"45","author":"L Rossignol","year":"2017","unstructured":"Rossignol L, Vaux S, Maugat S, Blake A, Barlier R, Heym B, et al. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study. Infection. 2017;45:33\u201340.","journal-title":"Infection."},{"key":"1374_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10096-015-2560-1","volume":"35","author":"A Malmartel","year":"2016","unstructured":"Malmartel A, Ghasarossian C. Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France. Eur J Clin Microbiol Infect Dis. 2016;35:447\u201351.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1374_CR18","doi-asserted-by":"publisher","first-page":"c2096","DOI":"10.1136\/bmj.c2096","volume":"340","author":"C Costelloe","year":"2010","unstructured":"Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.","journal-title":"BMJ."},{"key":"1374_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12879-019-3785-x","volume":"19","author":"H Kornf\u00e4lt Isberg","year":"2019","unstructured":"Kornf\u00e4lt Isberg H, Melander E, Hedin K, M\u00f6lstad S, Beckman A. Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment. BMC Infect Dis. 2019;19:155.","journal-title":"BMC Infect Dis"},{"key":"1374_CR20","unstructured":"Nederlands Huisartsen Genootschap. NHG Guidelines Urinary Tract Infections. https:\/\/www.nhg.org\/standaarden\/samenvatting\/urineweginfecties. Accessed 4 May 2020"},{"key":"1374_CR21","unstructured":"Overview | Urinary tract infection (lower): antimicrobial prescribing | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/NG109. Accessed 4 May 2020."},{"key":"1374_CR22","volume-title":"2012 Update of the IPDAS collaboration background document. IPDAS","author":"International Patient Decision Aid Standards","year":"2012","unstructured":"International Patient Decision Aid Standards. 2012 Update of the IPDAS collaboration background document. IPDAS; 2012. http:\/\/ipdas.ohri.ca\/resources.html."},{"key":"1374_CR23","doi-asserted-by":"publisher","unstructured":"Feldman-Stewart D, O\u2019Brien MA, Clayman ML, Davison BJ, Jimbo M, Labrecque M, et al. Providing information about options in patient decision aids. BMC Medical Informatics and Decision Making. 2013;13. https:\/\/doi.org\/10.1186\/1472-6947-13-S2-S4.","DOI":"10.1186\/1472-6947-13-S2-S4"},{"key":"1374_CR24","doi-asserted-by":"publisher","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5.","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"1374_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jclinepi.2011.10.007","volume":"65","author":"T van der Weijden","year":"2012","unstructured":"van der Weijden T, Boivin A, Burgers J, Sch\u00fcnemann HJ, Elwyn G. Clinical practice guidelines and patient decision aids. An inevitable relationship. J Clin Epidemiol. 2012;65:584\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1374_CR26","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1093\/jac\/dky321","volume":"73","author":"TEM van Esch","year":"2018","unstructured":"van Esch TEM, Brabers AEM, Hek K, van Dijk L, Verheij RA, de Jong JD. Does shared decision-making reduce antibiotic prescribing in primary care? J Antimicrob Chemother. 2018;73:3199\u2013205.","journal-title":"J Antimicrob Chemother"},{"key":"1374_CR27","unstructured":"Tools and resources | Urinary tract infection (lower): antimicrobial prescribing | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng109\/resources. Accessed 4 May 2020."},{"issue":"Suppl 2","key":"1374_CR28","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1472-6947-13-S2-S2","volume":"13","author":"A Coulter","year":"2013","unstructured":"Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1374_CR29","unstructured":"Ottawa Hospital Research Institute. Ottawa Personal Decision Guides - Patient Decision Aids. https:\/\/decisionaid.ohri.ca\/decguide.html. Accessed 6 May 2020."},{"key":"1374_CR30","unstructured":"Chaire de recherche du Canada sur la d\u00e9cision partag\u00e9e, Universit\u00e9 de Laval. Bo\u00eete \u00e0 d\u00e9cision. Bo\u00eete \u00e0 d\u00e9cision. http:\/\/www.decisionbox.ulaval.ca\/. Accessed 6 May 2020."},{"key":"1374_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.311.7000.299","volume":"311","author":"J Kitzinger","year":"1995","unstructured":"Kitzinger J. Qualitative research. Introducing focus groups. BMJ. 1995;311:299\u2013302.","journal-title":"BMJ."},{"key":"1374_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/bmjqs-2017-006986","volume":"27","author":"KR Sepucha","year":"2018","unstructured":"Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, et al. Standards for UNiversal reporting of patient decision aid evaluation studies: the development of SUNDAE checklist. BMJ Qual Saf. 2018;27:380\u20138.","journal-title":"BMJ Qual Saf"},{"key":"1374_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H. The qualitative content analysis process. J Adv Nurs. 2008;62:107\u201315.","journal-title":"J Adv Nurs"},{"key":"1374_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","volume":"333","author":"G Elwyn","year":"2006","unstructured":"Elwyn G, O\u2019Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.","journal-title":"BMJ"},{"key":"1374_CR35","first-page":"90","volume":"112","author":"J Dubi","year":"1982","unstructured":"Dubi J, Chappuis P, Darioli R. Treatment of urinary infection with a single dose of co-trimoxazole compared with a single dose of amoxicillin and a placebo. Schweiz Med Wochenschr. 1982;112:90\u20132.","journal-title":"Schweiz Med Wochenschr"},{"key":"1374_CR36","first-page":"695","volume":"22","author":"D Brooks","year":"1972","unstructured":"Brooks D, Garrett G, Hollihead R. Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. J R Coll Gen Pract. 1972;22:695\u2013703.","journal-title":"J R Coll Gen Pract"},{"issue":"Suppl 4","key":"1374_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003495-199100424-00005","volume":"42","author":"HW Asbach","year":"1991","unstructured":"Asbach HW. Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea. Drugs. 1991;42(Suppl 4):10\u20133.","journal-title":"Drugs."},{"key":"1374_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/02813430601183074","volume":"25","author":"SA Ferry","year":"2007","unstructured":"Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care. 2007;25:49\u201357.","journal-title":"Scand J Prim Health Care"},{"key":"1374_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1741-7015-8-30","volume":"8","author":"J Bleidorn","year":"2010","unstructured":"Bleidorn J, G\u00e1gyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - results of a randomized controlled pilot trial. BMC Med. 2010;8:30.","journal-title":"BMC Med"},{"key":"1374_CR40","doi-asserted-by":"publisher","first-page":"j4784","DOI":"10.1136\/bmj.j4784","volume":"359","author":"A Kronenberg","year":"2017","unstructured":"Kronenberg A, B\u00fctikofer L, Odutayo A, M\u00fchlemann K, da Costa BR, Battaglia M, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ. 2017;359:j4784.","journal-title":"BMJ."},{"key":"1374_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0025-7125(16)30455-2","volume":"75","author":"AR Ronald","year":"1991","unstructured":"Ronald AR, Pattullo ALS. The natural history of urinary infection in adults. Med Clin N Am. 1991;75:299\u2013312.","journal-title":"Med Clin N Am"},{"key":"1374_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0891-5520(03)00004-7","volume":"17","author":"TM Hooton","year":"2003","unstructured":"Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin N Am. 2003;17:303\u201332.","journal-title":"Infect Dis Clin N Am"},{"key":"1374_CR43","doi-asserted-by":"publisher","first-page":"b5633","DOI":"10.1136\/bmj.b5633","volume":"340","author":"P Little","year":"2010","unstructured":"Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ. 2010;340:b5633.","journal-title":"BMJ."},{"key":"1374_CR44","unstructured":"Vaginal Yeast Infection: Should I Treat It Myself? HealthLink BC. https:\/\/www.healthlinkbc.ca\/health-topics\/tn9593. Accessed 7 May 2020."},{"key":"1374_CR45","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jama.2018.3627","volume":"319","author":"A Huttner","year":"2018","unstructured":"Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, et al. Effect of 5-day Nitrofurantoin vs single-dose Fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women. JAMA. 2018;319:1781\u20139.","journal-title":"JAMA."},{"key":"1374_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cmi.2019.01.011","volume":"25","author":"M Moore","year":"2019","unstructured":"Moore M, Trill J, Simpson C, Webley F, Radford M, Stanton L, et al. Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. Clin Microbiol Infect. 2019;25:973\u201380.","journal-title":"Clin Microbiol Infect"},{"key":"1374_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000493368","volume":"101","author":"FM Wagenlehner","year":"2018","unstructured":"Wagenlehner FM, Abramov-Sommariva D, H\u00f6ller M, Steindl H, Naber KG. Non-antibiotic herbal therapy (BNO 1045) versus antibiotic therapy (Fosfomycin Trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre. Non-Inferiority Phase III Trial Urologia Internationalis. 2018;101:327\u201336.","journal-title":"Non-Inferiority Phase III Trial Urologia Internationalis"},{"key":"1374_CR48","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/1389201020666181206104129","volume":"19","author":"M Mantzorou","year":"2019","unstructured":"Mantzorou M, Giaginis C. Cranberry consumption against urinary tract infections: clinical Stateof- the-art and future perspectives. CPB. 2019;19:1049\u201363.","journal-title":"CPB."},{"key":"1374_CR49","doi-asserted-by":"publisher","unstructured":"Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD001321.pub5.","DOI":"10.1002\/14651858.CD001321.pub5"},{"key":"1374_CR50","first-page":"8","volume-title":"Les pratiques en m\u00e9decine g\u00e9n\u00e9rale dans cinq r\u00e9gions. Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques Etudes et R\u00e9sultats","author":"P Guerville","year":"2009","unstructured":"Guerville P, R\u00e9gi V, Ventelou V. Les pratiques en m\u00e9decine g\u00e9n\u00e9rale dans cinq r\u00e9gions. Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques Etudes et R\u00e9sultats; 2009. p. 8."},{"key":"1374_CR51","doi-asserted-by":"publisher","first-page":"233339361663046","DOI":"10.1177\/2333393616630466","volume":"3","author":"AP Tausch","year":"2016","unstructured":"Tausch AP, Menold N. Methodological aspects of focus groups in Health Research: results of qualitative interviews with focus group moderators. Global Qualitative Nursing Research. 2016;3:233339361663046.","journal-title":"Global Qualitative Nursing Research"},{"key":"1374_CR52","doi-asserted-by":"publisher","unstructured":"L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. The Cochrane Database of Systematic Reviews. 2017;2017. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5.","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"1374_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pec.2007.03.023","volume":"67","author":"A Loh","year":"2007","unstructured":"Loh A, Simon D, Wills CE, Kriston L, Niebling W, H\u00e4rter M. The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns. 2007;67:324\u201332.","journal-title":"Patient Educ Couns"},{"key":"1374_CR54","doi-asserted-by":"publisher","first-page":"c199","DOI":"10.1136\/bmj.c199","volume":"340","author":"P Little","year":"2010","unstructured":"Little P, Moore MV, Turner S, Rumsby K, Warner G, Lowes JA, et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010;340:c199.","journal-title":"BMJ."}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-021-01374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12875-021-01374-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-021-01374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T16:20:18Z","timestamp":1611678018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-021-01374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/s12875-021-01374-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-35154\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35154\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35154\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35154\/v1","asserted-by":"object"}]},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have the agreement of the French CNIL (Commission Nationale de l\u2019Informatique et des Libert\u00e9s) for our work.Our Referent was Chantal Durand from the CHU of Bordeaux.We obtain written and oral consent from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}